EFCG Ratifies FDA's Proposed Generic Drug User Fees Act
11:58 AM | September 13, 2011 | Deepti Ramesh
The European Fine Chemicals Group (EFCG; Brussels) says its board has agreed to ratify the proposal of the U.S. Food and Drug Administration (FDA) to put forward a legislative package, designed with...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.